Single-cell analyses of transcriptional heterogeneity during drug tolerance transition in cancer cells by RNA sequencing

Significance Tumor cells are heterogeneous, and much variation occurs at the single-cell level, which may contribute to therapeutic response. Here, we studied drug resistance dynamics in a model of tolerance with a metastatic breast cancer cell line by leveraging the power of single-cell RNA-Seq technology. Drug-tolerant cells within a single clone rapidly express high cell-to-cell transcript variability, with a gene expression profile similar to untreated cells, and the population reacquires paclitaxel sensitivity. Our gene expression and single nucleotide variants analyses suggest that equivalent phenotypes are achieved without relying on a unique molecular event or fixed transcriptional programs. Thus, transcriptional heterogeneity might ensure survival of cancer cells with equivalent combinations of gene expression programs and/or single nucleotide variants. The acute cellular response to stress generates a subpopulation of reversibly stress-tolerant cells under conditions that are lethal to the majority of the population. Stress tolerance is attributed to heterogeneity of gene expression within the population to ensure survival of a minority. We performed whole transcriptome sequencing analyses of metastatic human breast cancer cells subjected to the chemotherapeutic agent paclitaxel at the single-cell and population levels. Here we show that specific transcriptional programs are enacted within untreated, stressed, and drug-tolerant cell groups while generating high heterogeneity between single cells within and between groups. We further demonstrate that drug-tolerant cells contain specific RNA variants residing in genes involved in microtubule organization and stabilization, as well as cell adhesion and cell surface signaling. In addition, the gene expression profile of drug-tolerant cells is similar to that of untreated cells within a few doublings. Thus, single-cell analyses reveal the dynamics of the stress response in terms of cell-specific RNA variants driving heterogeneity, the survival of a minority population through generation of specific RNA variants, and the efficient reconversion of stress-tolerant cells back to normalcy.

[1]  H. Ueda,et al.  Erratum to: Quartz-Seq: a highly reproducible and sensitive single-cell RNA sequencing method, reveals non-genetic gene-expression heterogeneity , 2017, Genome Biology.

[2]  A. Saliba,et al.  Single-cell RNA-seq: advances and future challenges , 2014, Nucleic acids research.

[3]  Jian Lu,et al.  Extensive pathogenicity of mitochondrial heteroplasmy in healthy human individuals , 2014, Proceedings of the National Academy of Sciences.

[4]  N. Xu,et al.  CDK1 switches mitotic arrest to apoptosis by phosphorylating Bcl‐2/Bax family proteins during treatment with microtubule interfering agents , 2014, Cell biology international.

[5]  B. Williams,et al.  From single-cell to cell-pool transcriptomes: Stochasticity in gene expression and RNA splicing , 2014, Genome research.

[6]  Joshua M. Stuart,et al.  RADIA: RNA and DNA Integrated Analysis for Somatic Mutation Detection , 2014, PloS one.

[7]  C. Ponting,et al.  Sequencing depth and coverage: key considerations in genomic analyses , 2014, Nature Reviews Genetics.

[8]  Steven R. Head,et al.  Technical Variations in Low-Input RNA-seq Methodologies , 2014, Scientific Reports.

[9]  Gioele La Manno,et al.  Quantitative single-cell RNA-seq with unique molecular identifiers , 2013, Nature Methods.

[10]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[11]  N. Neff,et al.  Quantitative assessment of single-cell RNA-sequencing methods , 2013, Nature Methods.

[12]  Alan Jones,et al.  To whom correspondence should be addressed , 2014 .

[13]  M. Wicha,et al.  Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells , 2013, PloS one.

[14]  F. Gage,et al.  RNA-sequencing from single nuclei , 2013, Proceedings of the National Academy of Sciences.

[15]  Laura M. Heiser,et al.  Modeling precision treatment of breast cancer , 2013, Genome Biology.

[16]  Ruiqiang Li,et al.  Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells , 2013, Nature Structural &Molecular Biology.

[17]  T. Masuda,et al.  BCL2 and BCLxL are key determinants of resistance to antitubulin chemotherapeutics in melanoma cells , 2013, Experimental dermatology.

[18]  D. Yardley,et al.  Drug Resistance and the Role of Combination Chemotherapy in Improving Patient Outcomes , 2013, International journal of breast cancer.

[19]  P. Gascard,et al.  Coordinate transcriptional and translational repression of p53 by TGF-β1 impairs the stress response. , 2013, Molecular cell.

[20]  Rona S. Gertner,et al.  Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells , 2013, Nature.

[21]  Rahul Kumar,et al.  CancerDR: Cancer Drug Resistance Database , 2013, Scientific Reports.

[22]  Jin Billy Li,et al.  Edinburgh Research Explorer Identifying Rna Editing Sites Using Rna Sequencing Data Alone , 2022 .

[23]  Kornelia Polyak,et al.  Cellular heterogeneity and molecular evolution in cancer. , 2013, Annual review of pathology.

[24]  Kendra N. Pesko,et al.  Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification , 2012, Nucleic acids research.

[25]  P. Mariani,et al.  Assessment of MDA efficiency for genotyping using cloned embryo biopsies. , 2013, Genomics.

[26]  Jiang Li,et al.  The effect of strand bias in Illumina short-read sequencing data , 2012, BMC Genomics.

[27]  M. Ronaghi,et al.  mRNA-Seq of Single Prostate Cancer Circulating Tumor Cells Reveals Recapitulation of Gene Expression and Pathways Found in Prostate Cancer , 2012, PloS one.

[28]  A. Wilm,et al.  LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets , 2012, Nucleic acids research.

[29]  C. Swanton Intratumor heterogeneity: evolution through space and time. , 2012, Cancer research.

[30]  T. Hashimshony,et al.  CEL-Seq: single-cell RNA-Seq by multiplexed linear amplification. , 2012, Cell reports.

[31]  Jacek Majewski,et al.  RNA editing of protein sequences: a rare event in human transcriptomes. , 2012, RNA.

[32]  B. Williams,et al.  RNA editing in the human ENCODE RNA-seq data , 2012, Genome research.

[33]  Wei Li,et al.  RSeQC: quality control of RNA-seq experiments , 2012, Bioinform..

[34]  H. Swerdlow,et al.  A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers , 2012, BMC Genomics.

[35]  Richard S. Sandstrom,et al.  BEDOPS: high-performance genomic feature operations , 2012, Bioinform..

[36]  R. Minchin,et al.  Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives , 2012, EMBO molecular medicine.

[37]  R. Sandberg,et al.  Full-Length mRNA-Seq from single cell levels of RNA and individual circulating tumor cells , 2012, Nature Biotechnology.

[38]  Thomas Lengauer,et al.  Managing drug resistance in cancer: lessons from HIV therapy , 2012, Nature Reviews Cancer.

[39]  Matthew A. Hibbs,et al.  Canonical A-to-I and C-to-U RNA Editing Is Enriched at 3′UTRs and microRNA Target Sites in Multiple Mouse Tissues , 2012, PloS one.

[40]  William A. Walters,et al.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms , 2012, The ISME Journal.

[41]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[42]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[43]  Huanming Yang,et al.  Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor , 2012, Cell.

[44]  Wenwei Zhang,et al.  Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome , 2012, Nature Biotechnology.

[45]  Mark A van de Wiel,et al.  BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain , 2012, The Journal of pathology.

[46]  Ken Chen,et al.  SomaticSniper: identification of somatic point mutations in whole genome sequencing data , 2012, Bioinform..

[47]  Kazuhiro Morishita,et al.  The Increased Expression of Integrin α6 (ITGA6) Enhances Drug Resistance in EVI1high Leukemia , 2012, PloS one.

[48]  T. Crook,et al.  Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells , 2012, Cell Death and Disease.

[49]  J. Z. Sanborn Tumor versus Matched-Normal Sequencing Analysis and Data Integration , 2012 .

[50]  Jae-Hyung Lee,et al.  Accurate identification of A-to-I RNA editing in human by transcriptome sequencing. , 2012, Genome research.

[51]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[52]  M. Ruíz-Borrego,et al.  Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction , 2012, Breast Cancer Research and Treatment.

[53]  C. Baines,et al.  The mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell death , 2011, Cell cycle.

[54]  Pradeep S Rajendran,et al.  Single-cell dissection of transcriptional heterogeneity in human colon tumors , 2011, Nature Biotechnology.

[55]  R. Bast,et al.  Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel. , 2011, Cancer research.

[56]  Nader Pourmand,et al.  Whole-transcriptome RNAseq analysis from minute amount of total RNA , 2011, Nucleic acids research.

[57]  S. Linnarsson,et al.  Characterization of the single-cell transcriptional landscape by highly multiplex RNA-seq. , 2011, Genome research.

[58]  G. Heusch,et al.  Nuclear-encoded mitochondrial proteins and their role in cardioprotection. , 2011, Biochimica et biophysica acta.

[59]  Xiaolong Yang,et al.  Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. , 2011, Cancer research.

[60]  T. Merriam,et al.  Apoptosis induces Bcl-XS and cleaved Bcl-XL in chronic lymphocytic leukaemia. , 2011, Biochemical and biophysical research communications.

[61]  Elaine R. Mardis,et al.  A decade’s perspective on DNA sequencing technology , 2011, Nature.

[62]  A. Pobbati,et al.  Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin* , 2011, The Journal of Biological Chemistry.

[63]  F. Kronenberg,et al.  Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients. , 2010, American journal of human genetics.

[64]  Jonathan W. Pillow,et al.  POSTER PRESENTATION Open Access , 2013 .

[65]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[66]  B. Ward,et al.  Transplex? Whole Transcriptome Amplification of RNA from Low Cell-Number Samples. , 2010 .

[67]  Yu Shyr,et al.  RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells , 2010, Breast Cancer Research.

[68]  K. Nishikura Functions and regulation of RNA editing by ADAR deaminases. , 2010, Annual review of biochemistry.

[69]  Wei Xiong,et al.  MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression* , 2010, The Journal of Biological Chemistry.

[70]  Ben S. Wittner,et al.  A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations , 2010, Cell.

[71]  Catalin C. Barbacioru,et al.  RNA-Seq analysis to capture the transcriptome landscape of a single cell , 2010, Nature Protocols.

[72]  L. Tsai,et al.  Hook3 Interacts with PCM1 to Regulate Pericentriolar Material Assembly and the Timing of Neurogenesis , 2010, Neuron.

[73]  S. Brunak,et al.  Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis , 2010, Science Signaling.

[74]  Ashraful Hoque,et al.  Single nucleotide differences (SNDs) in the dbSNP database may lead to errors in genotyping and haplotyping studies , 2010, Human mutation.

[75]  Xuegong Zhang,et al.  DEGseq: an R package for identifying differentially expressed genes from RNA-seq data , 2010, Bioinform..

[76]  Yuan Tian,et al.  Quantitative proteomic analysis of ovarian cancer cells identified mitochondrial proteins associated with paclitaxel resistance , 2009, Proteomics. Clinical applications.

[77]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[78]  Lior Pachter,et al.  Sequence Analysis , 2020, Definitions.

[79]  Huilin Zhou,et al.  hNOA1 Interacts with Complex I and DAP3 and Regulates Mitochondrial Respiration and Apoptosis* , 2009, Journal of Biological Chemistry.

[80]  N. Samadi,et al.  Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis , 2009, Oncogene.

[81]  N. Tanaka,et al.  Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer. , 2009, International journal of oncology.

[82]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[83]  G. Hortobagyi,et al.  Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells , 2009, Breast Cancer Research.

[84]  A. Letai,et al.  Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737. , 2008, Cancer research.

[85]  G. Glatting,et al.  Activation of intrinsic apoptotic pathway by Re-188 irradiation and paclitaxel in coronary artery smooth muscle cells. , 2008, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[86]  S. Elledge,et al.  A quantitative atlas of mitotic phosphorylation , 2008, Proceedings of the National Academy of Sciences.

[87]  S. Carr,et al.  A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology , 2008, Cell.

[88]  B. Williams,et al.  Mapping and quantifying mammalian transcriptomes by RNA-Seq , 2008, Nature Methods.

[89]  Sherif Abou Elela,et al.  Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes , 2008, Molecular Cancer Therapeutics.

[90]  Barbara McGrogan,et al.  Taxanes, microtubules and chemoresistant breast cancer. , 2008, Biochimica et biophysica acta.

[91]  Sébastien Lê,et al.  FactoMineR: An R Package for Multivariate Analysis , 2008 .

[92]  Nanlan Xu,et al.  Whole genome amplification using single‐primer PCR , 2008, Biotechnology journal.

[93]  Seema Sehrawat,et al.  Role of Epac1, an exchange factor for Rap GTPase, in endothelial microtubule dynamics and barrier function , 2007, Molecular biology of the cell.

[94]  Shawn Levy,et al.  Complementary RNA amplification methods enhance microarray identification of transcripts expressed in the C. elegans nervous system , 2008, BMC Genomics.

[95]  Pierre Baldi,et al.  An enhanced MITOMAP with a global mtDNA mutational phylogeny , 2006, Nucleic Acids Res..

[96]  Marty C. Brandon,et al.  Mitochondrial mutations in cancer , 2006, Oncogene.

[97]  Sambasiva P Rao,et al.  Accurate and precise transcriptional profiles from 50 pg of total RNA or 100 flow-sorted primary lymphocytes. , 2006, Genomics.

[98]  E. Thompson,et al.  Evi1 is a survival factor which conveys resistance to both TGFβ- and taxol-mediated cell death via PI3K/AKT , 2006, Oncogene.

[99]  Hidetoshi Shimodaira,et al.  Pvclust: an R package for assessing the uncertainty in hierarchical clustering , 2006, Bioinform..

[100]  Xiaoqi Liu,et al.  A mammalian NudC-like protein essential for dynein stability and cell viability. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[101]  Huai-gu Zhou,et al.  [Study on application of the whole genome amplification in LCN]. , 2006, Fa yi xue za zhi.

[102]  Anne Kopf-Sill,et al.  Novel isothermal, linear nucleic acid amplification systems for highly multiplexed applications. , 2005, Clinical chemistry.

[103]  M. Magiera,et al.  Exchange protein directly activated by cAMP (EPAC) interacts with the light chain (LC) 2 of MAP1A. , 2004, The Biochemical journal.

[104]  Xiaoju Wang,et al.  Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer , 2004, Cancer Research.

[105]  Ming-Tsan Lin,et al.  Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-κB-dependent XIAP Up-Regulation* , 2004, Journal of Biological Chemistry.

[106]  Zhuchu Chen,et al.  [Expression and structure of BNIP3L in lung cancer]. , 2004, Ai zheng = Aizheng = Chinese journal of cancer.

[107]  Terrence S. Furey,et al.  The UCSC Table Browser data retrieval tool , 2004, Nucleic Acids Res..

[108]  M. Campbell,et al.  PANTHER: a library of protein families and subfamilies indexed by function. , 2003, Genome research.

[109]  M. Raffeld,et al.  The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation. , 2003, Blood.

[110]  Xiaoqi Liu,et al.  A role for Plk1 phosphorylation of NudC in cytokinesis. , 2003, Developmental cell.

[111]  S. Dimauro,et al.  Mitochondrial respiratory-chain diseases. , 2003, The New England journal of medicine.

[112]  F. J. Livesey Strategies for microarray analysis of limiting amounts of RNA. , 2003, Briefings in functional genomics & proteomics.

[113]  A. Merdes,et al.  Assembly of centrosomal proteins and microtubule organization depends on PCM-1 , 2002, The Journal of cell biology.

[114]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[115]  W. J. Kent,et al.  BLAT--the BLAST-like alignment tool. , 2002, Genome research.

[116]  M. Gottesman Mechanisms of cancer drug resistance. , 2002, Annual review of medicine.

[117]  M. Mann,et al.  p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[118]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[119]  田上 真次 A novel protein,RTN-xS,interacts with both Bcl-xL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity , 2001 .

[120]  M. Takeda,et al.  A novel protein, RTN-xS, interacts with both Bcl-xL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity , 2000, Oncogene.

[121]  T. Lüscher,et al.  Connective Tissue Growth Factor Induces Apoptosis in Human Breast Cancer Cell Line MCF-7* , 1999, The Journal of Biological Chemistry.

[122]  M. Tattersall,et al.  Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[123]  K. Sirotkin,et al.  dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. , 1999, Genome research.

[124]  J. Ingle,et al.  Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[125]  T. Fujiwara,et al.  Isolation, mapping, and functional analysis of a novel human cDNA (BNIP3L) encoding a protein homologous to human NIP3 , 1998, Genes, chromosomes & cancer.

[126]  B. Brinkley,et al.  Supernumerary centrosomes and cancer: Boveri's hypothesis resurrected. , 1998, Cell motility and the cytoskeleton.

[127]  Stuart Tugendreich,et al.  CDC27Hs colocalizes with CDC16Hs to the centrosome and mitotic spindle and is essential for the metaphase to anaphase transition , 1995, Cell.

[128]  B. Pedrotti,et al.  Purified native microtubule associated protein MAP1A: kinetics of microtubule assembly and MAP1A/tubulin stoichiometry. , 1994, Biochemistry.

[129]  J. W. Wilson,et al.  Taxol: a history of pharmaceutical development and current pharmaceutical concerns. , 1993, Journal of the National Cancer Institute. Monographs.

[130]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[131]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.

[132]  城所 良明,et al.  The Salk Institute for Biological Studies(話題) , 1975 .